1COV.DE · Intrinsic value
Is Covestro AG (1COV.DE) overvalued or undervalued?
Covestro AG (1COV.DE) trades at the delayed market price of €59.10 a share. That price already implies revenue growth of 21.4% a year for 5 years. TickerWorth's fair value is €22.67 a share (161% above fair value), as of Oct 19, 2026. It is a model estimate, and every input behind it is sourced below.
Model by Miraaj Patel · generated from market data · Updated Oct 19, 2026 · How these pages are made
Is 1COV.DE overvalued?
- Fair value
- €22.67
- Market price
- €59.10
- Downside to fair value
- 61.6%
- Verdict
- 161% above fair value
Reverse DCF: Today's price implies revenue growth of 21.4% a year for 5 years; our model assumes 1.8% a year on average over the same horizon.
What is 1COV.DE's TickerWorth Score?
Middle of the pack — real strengths and real weaknesses
Compared with Other companies in Europe
Its strongest point: a profitable, high-quality business. Its weakest: trades above our estimate of what it's worth.
- Value · 56 of 100
Cheaper than 56% of companies we track
- Price vs worth · 1 of 100
- Quality · 72 of 100
More profitable than 72% of companies we track
- Financial health · 40 of 100
Financially stronger than 40% of companies we track
- Growth · 60 of 100
Growing faster than 60% of companies we track
- Momentum · 53 of 100
Outperformed 53% of companies we track over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
1COV.DE DCF valuation: what the price assumes
At a recent price of €59.10, Covestro AG (1COV.DE) trades 161% above TickerWorth's blended fair value of €22.67 per share — a discounted-cash-flow model cross-checked against peer multiples and asset value — meaning the market currently prices 1COV.DE overvalued vs our estimate of what the business is intrinsically worth. Our fair value sits below the market, an implied -61.6% move to close the gap if the business performs in line with our assumptions. This is an educational model, not a price target or a recommendation — the value moves with the inputs, which you can test yourself using the WACC slider below.
Read the full reasoning
One of the lenses behind that blended figure is a discounted-cash-flow model, which on its own values 1COV.DE at about €20.97 per share. The rest of this page walks through that DCF — its assumptions, reverse-DCF and discount-rate sensitivity — because it is the auditable anchor of the blend.
The valuation discounts Covestro AG's projected free cash flows at a weighted-average cost of capital (WACC) of 8.8%, with a long-run terminal growth rate of 2.5%. About 74% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 21.4% annual revenue growth for 1COV.DE. Our base case instead compounds to about 1.8% a year over the same forecast, so the market is pricing in materially faster growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, 1COV.DE's modeled DCF value ranges from about €12.90 to €39.66 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what Covestro AG would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of 1COV.DE's intrinsic value. Figures update as new filings and prices come in.
Every input behind 1COV.DE's DCF
| Input | Value |
|---|---|
| Base-year revenueLive feed — totalRevenue (TTM) | €12,815,000,000 |
| Base EBIT marginComputed — trailing operatingMargins, held roughly flat | 3.6% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | -0% → 1% → 2% → 3% → 4% |
| Risk-free rateLive feed — US 10-year Treasury yield (^TNX) | 5.1% |
| BetaLive feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) | 0.94 |
| Terminal growthESTIMATEAssumption — TickerWorth house default 2.5%, held below WACC | 2.5% |
| Diluted sharesLive feed — sharesOutstanding | 189M |
| Market priceDelayed quote · as of 2026-10-19 17:02 UTC | €59.10 |
Change 1COV.DE's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does Covestro AG do?
What does it do?
Covestro AG operates as a supplier of polymer materials and application solutions. The company operates in two segments, Performance Materials, and Solutions & Specialties. The company employs roughly 17,413 people.
How does it make money?
The business turns 12.8B in annual revenue into profit. Out of every $100 of sales, about $4 is left as operating profit (operating margin of 3.6%), after a 16% gross margin on the products/services it sells. After all costs, taxes and interest, -2.4% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries modest debt (0.4× equity), comfortably covers its short-term bills (1.7× current ratio), and is currently lossmaking.
1COV.DE insider trading
Insider filings are available for US-listed companies only.
Common questions
What is 1COV.DE's intrinsic value?
TickerWorth's blended fair value for Covestro AG (1COV.DE) is €22.67 per share, versus a market price of €59.10 (161% above fair value).
Is 1COV.DE overvalued or undervalued?
On our blended fair value 1COV.DE looks overvalued vs fair value at €59.10. This is an educational estimate, not advice.
What discount rate is used for 1COV.DE?
A WACC of 8.8% and a terminal growth rate of 2.5%.
Is Covestro stock undervalued?
TickerWorth's fair value for Covestro AG (1COV.DE) is €22.67 against a market price of €59.10. Our read: 161% above fair value. This is a model estimate, not investment advice.
Covestro (1COV.DE) DCF valuation and fair value
Our fair value for Covestro AG (1COV.DE) is €22.67, built on a 8.8% discount rate (WACC) and 2.5% terminal growth. It blends our discounted-cash-flow model with other valuation lenses. Every assumption is listed on this page with its source.
What growth is priced into Covestro stock?
Today's price implies revenue growth of 21.4% a year for 5 years; our model assumes 1.8% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of €59.10. A model estimate, not investment advice.
Covestro (1COV.DE) insider trading
We have no recent SEC Form 4 insider filings on file for Covestro AG (1COV.DE). Form 4 covers US-listed companies only.
Stocks below our fair value instead
Not investment advice. TickerWorth Score is a model output.
Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.